Savient Pharma: Still Struggling to Grow KRYSTEXXA Sales

Savient Pharma: Still Struggling To Grow KRYSTEXXA Sales

Filed under: drug treatment news articles

The company reported disappointing sales numbers for the promising gout drug and failed to break out one-time costs to provide investors a clearer picture of the 2013 earnings view. As written in a previous article, Savient Pharma: The Pharma Rising …
Read more on Seeking Alpha

Durect Corporation – Insider Activity Report

Filed under: drug treatment news articles

I have no business relationship with any company whose stock is mentioned in this article. … It focuses on the development of products for the treatment of various chronic and episodic disease areas, such as pain, central nervous system disorders …
Read more on Seeking Alpha

Big disappointment in brain injury treatment study

Filed under: drug treatment news articles

The supplement is marketed as a memory booster online and in over-the-counter powders and drinks. It is also widely used by doctors in dozens of countries to treat traumatic brain injuries and strokes, although evidence on whether it works has been mixed.
Read more on KOB.com